Botulinum Toxin Type A for Treating Voice Tremor
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Voice tremor, like spasmodic dysphonia and other tremor disorders, may respond to botulinum toxin type A injections. OBJECTIVE: To evaluate the safety and efficacy of botulinum toxin type A injections as treatment for voice tremor. DESIGN: A randomized study of 3 doses of botulinum toxin type A with 6 weeks of follow-up. SETTING: A single-site tertiary care center. PARTICIPANTS AND METHODS: Thirteen subjects (11 women, 2 men; mean age, 73 years) with voice tremor and no spasmodic dysphonia or head, mouth, jaw, or facial tremor were entered into this study. Patients received 1.25 U (n = 5), 2.5 U (n = 5), or 3.75 U (n = 3) of botulinum toxin type A in each vocal cord. All patients were evaluated at baseline and postinjection at weeks 2, 4, and 6. MAIN OUTCOME MEASURES: The primary outcome measure was the patient tremor rating scale, with secondary measures including patient-rated functional disability, response rating scale, independent randomized tremor ratings, and acoustical measures. RESULTS: All patients at all dose levels noted an effect from the injection. The mean time to onset of effect was 2.3 days (range, 1-7 days). For all patients combined, mean tremor severity scale scores (rated by patients on a 5-point scale) improved 1.4 points at week 2, 1.6 points at week 4, and 1.7 points at week 6. Measures of functional disability, measures of the effect of injection, independent ratings of videotaped speech, and acoustic measures of tremor also showed improvement. The main adverse effects at all doses were breathiness and dysphagia. CONCLUSION: Voice tremor improves following injections of botulinum toxin type A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J. (1996) · Movement Disorders · doi:10.1002/mds.870110306 · Cited by 235
Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor
Kumar, R., Lozano, A. M., Sime, E., & Lang, A. E. (2003) · Neurology · doi:10.1212/01.wnl.0000096012.07360.1c · Cited by 210
Cited by
Simpson, D. M., Blitzer, A., Brashear, A., Comella, C., Dubinsky, R., Hallett, M., Jankovic, J., Karp, B., Ludlow, C. L., Miyasaki, J. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311389.26145.95 · Cited by 618
Treatment of patients with essential tremor
Deuschl, G., Raethjen, J., Hellriegel, H., & Elble, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70322-7 · Cited by 428
Transducer‐based evaluation of tremor
Haubenberger, D., Abbruzzese, G., Bain, P. G., Bajaj, N., Benito‐León, J., Bhatia, K. P., Deuschl, G., Forjaz, M. J., Hallett, M., Louis, E. D., et al. (2016) · Movement Disorders · doi:10.1002/mds.26671 · Cited by 87
Treatment for spasmodic dysphonia: limitations of current approaches
Ludlow, C. L. (2009) · Current Opinion in Otolaryngology & Head and Neck Surgery · doi:10.1097/moo.0b013e32832aef6f · Cited by 84
The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients
Patel, A. B., Bansberg, S. F., Adler, C. H., Lott, D. G., & Crujido, L. (2015) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/0003489415588557 · Cited by 60
Self-citation
Metadata
- Authors
- Adler, C. H., Bansberg, S. F., Hentz, J. G., Ramig, L. O., Buder, E. H., Witt, K., Edwards, B. W., Krein-Jones, K., & Caviness, J. N.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-09-01
- Volume
- 61
- Issue
- 9
- Pages
- 1416
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2147396729
- Cited by
- 103
- References
- 2
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Botulinum Toxin Type A for Treating Voice Tremor. https://app.cochat.ai/papers/10.1001/archneur.61.9.1416
- The paper
- Adler, C. H., Bansberg, S. F., Hentz, J. G., Ramig, L. O., Buder, E. H., Witt, K., Edwards, B. W., Krein-Jones, K., & Caviness, J. N. (2004). Botulinum Toxin Type A for Treating Voice Tremor. Archives of Neurology. https://doi.org/10.1001/archneur.61.9.1416
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.